Medical equipment and pharmaceuticals
Originaltitel der Bekanntmachung
United Kingdom-Croydon: Medical equipments, pharmaceuticals and personal care products
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
65 / 100
Risikofaktoren
Critical missing data: estimated value, detailed selection criteria, and award criteria per lot.
Restricted procedure with selection questionnaire may exclude suppliers that do not meet financial or statutory thresho...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Supplies contract
- 3 lots
- Supply of moving and handling equipment for Croydon Council's Community Equipment Service.
- 36 lots covering hoists (electric, standing, ceiling track), slings (various types), transfer aids (discs, boards, belts), slide sheets, bed sheets, handling belts, and accessories.
Vollständige Zusammenfassung anzeigen
Croydon Council is establishing a Dynamic Purchasing System (DPS) for Moving and Handling Equipment for a duration of 7+3 years. The DPS is divided into 36 lots covering hoists, slings, slide sheets, transfer boards, and related equipment. The procedure is restricted, and the notice type indicates a DPS. No estimated value is provided. The deadline for receipt of tenders via the London Tenders portal is 2029-02-13 17:00. Only the TED XML notice was analyzed.
Risiken
Critical missing data: estimated value, detailed selection criteria, and award criteria per lot.
Restricted procedure with selection questionnaire may exclude suppliers that do not meet financial or statutory thresho...
Restricted procedure — pre-qualification required
No procurement documents available
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Suppliers must complete the mandatory selection questionnaire on the London Tenders portal to qualify for the DPS.
- Tender validity period: 3 months.
Administrative
- Tenders must be submitted electronically via the London Tenders portal (Portal öffnen).
Auftraggeber
Lose (3)
1
Standard Electric Hoist
A mobile electric operated mechanism, using a magnetic handset, to lift a person on/off a bed, chair, commode or toilet and lower to or lift from the floor.
Kategorie
Zusätzliche CPV-Codes
2
Bariatric Electric Hoist
A mobile electric operated mechanism, using a magnetic handset, to lift a person on/off a bed, chair, commode or toilet and lower to or lift from the floor.
Kategorie
Zusätzliche CPV-Codes
3
Electric Standing Hoist — Bedhead
A freestanding portable electrically operated hoist to lift service users on/off a bed. Includes emergency lowering option.
Kategorie
Zusätzliche CPV-Codes
Vergabedetails
- Veröffentlichungsdatum
- 13 Feb 2019
- Sprachen
- English
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 71486-2019
Ähnliche Ausschreibungen
Czechia – Magnetic resonance unit – Magnetická rezonance (MRI) pro Karlovarskou krajskou nemocnici a.s., Nemocnici Cheb
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Omalizumab (ATC-Code nach WHO: R03DX05)
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
65 / 100
Risikofaktoren
Critical missing data: estimated value, detailed selection criteria, and award criteria per lot.
Restricted procedure with selection questionnaire may exclude suppliers that do not meet financial or statutory thresho...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications